Angiogenesis, which is essential for cancer growth, is a diagnostic and therapeutic target

Journal of Gastroenterology

Volumn 40, Issue 3, 2005, Pages 320-321

  Nishida, Toshirou ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; FLUORODEOXYGLUCOSE; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SHU 508; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BASEMENT MEMBRANE; CANCER DIAGNOSIS; CANCER GROWTH; CELL INTERACTION; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG RESPONSE; DRUG TARGETING; ECHOGRAPHY; EDITORIAL; ENDOTHELIUM CELL; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PERICYTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION; TUMOR VOLUME;

DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INTESTINAL MUCOSA; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 18144366583     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-005-1588-x     Document Type: Editorial

References (10)

1. Tonini T, Rossi F, Claudio PP. Molecular basis of angiogenesis and cancer. Oncogene 2003;22:6549-56.
2. Schaefer JF, Vollmar J, Schick F, Vonthein R, Seemann MD, Aebert H, et al. Solitary pulmonary nodules: Dynamic contrastenhanced MR imaging - perfusion differences in malignant and benign lesions. Radiology 2004;232:544-53.
3. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94:883-93.
4. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 2000;97:14 608-13.
5. Nishida T, Hirota S. Biological and clinical review of stromal tumors in the gastrointestinal tract. Histol Histopathol 2000;15: 1293-301.
6. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004;22:3813-25.
7. Nishida T, Kumano S, Sugiura T, Ikushima H, Nishikawa K, Ito T, et al. Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors. AJR Am J Roentgenol 2003;180: 185-9.
8. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33:459-65.
9. Fukuta N, Kitano M, Maekawa K, Chikugo T, Kudo M. Estimation of the malignant potential of gastrointestinal stromal tumors: The value of contrast-enhanced coded phase-inversion harmonics US. J Gastroenterol 2005;40:247-55.
10. Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: A quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004;183:1619-28.